Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
AGS-v PLUS by Imutex for West Nile Encephalitis (West Nile Fever): Likelihood of Approval
AGS-v PLUS is under clinical development by Imutex and currently in Phase I for West Nile Encephalitis (West Nile Fever)....
Data Insights
AGS-v PLUS by Imutex for Zika Virus Infections: Likelihood of Approval
AGS-v PLUS is under clinical development by Imutex and currently in Phase I for Zika Virus Infections. According to GlobalData,...